Diarrhea

Products Diarrhea

LightCycler® Real-Time PCR Systems for EHEC identification

Fast, reliable detection of the EHEC bacterium is essential for monitoring and controlling EHEC infections. The most appropriate targets for the rapid more

News Diarrhea

• Successful results in developing oral vaccin against diarrhea
  

  The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of diarrhea in children living in low a more

• “Gut”-throat competition: U-M research on digestive tract bacteria yields surprising findings

  From tiny villages in developing nations to suburban kitchens in the United States, dangerous strains of E. coli bacteria sicken millions of people each year – and kill untold numbers of children. Now, new research from the University of Michigan Health System gives scientists a better understanding more

• Intercell announces first data from its Phase I clinical trial with vaccine candidate to prevent Clostridium difficile infections

  Intercell AG announced first data from a Phase I clinical trial with the companyʹs vaccine candidate IC84 to prevent disease caused by the bacterium Clostridium difficile (C. difficile). The pathogen is one of the main causes of nosocomial diarrhea. Intercellʹs vaccine candidate is a recombinant pro more

Publications Diarrhea

• Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic

  Clostridium difficile infection, also known as C. difficile‐associated diarrhea (CDAD), is the most common cause of nosocomial diarrhea, typically initiated by the use of broad‐spectrum antibiotics that disrupt gut flora, thereby allowing C. difficile to proliferate. It is an increasing cause of m more

• Adaptive Mutations and Replacements of Virulence Traits in the Escherichia coli O104:H4 Outbreak Population

  by Lionel Guy, Cecilia Jernberg, Jenny Arvén Norling, Sofie Ivarsson, Ingela Hedenström, Öjar Melefors, Ulrika Liljedahl, Lars Engstrand, Siv G. E. Andersson The sequencing of highly virulent Escherichia coli O104:H4 strains isolated during the outbreak of bloody diarrhea and hemolytic uremic syn more

• Genome-Wide Identification of Regulatory RNAs in the Human Pathogen Clostridium difficile

  by Olga A. Soutourina, Marc Monot, Pierre Boudry, Laure Saujet, Christophe Pichon, Odile Sismeiro, Ekaterina Semenova, Konstantin Severinov, Chantal Le Bouguenec, Jean-Yves Coppée, Bruno Dupuy, Isabelle Martin-Verstraete Clostridium difficile is an emergent pathogen, and the most common cause of more

Market studies Diarrhea

• Diarrhea – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Diarrhea - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diarrhea, complete with latest updates, and special features on late-stage and discontinue more

• Diarrhea – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Diarrhea - Pipeline Review, H1 2012', provides an overview of the Diarrhea therapeutic pipeline. This report provides information on the therapeutic development for Diarrhea, complete with latest updates, and special features on late-stage and discontinued pr more

• Diarrhea Global Clinical Trials Review, H1, 2012

  Introduction GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H1, 2012" provides data on the Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diarrhea. It includes an overview of the trial numbers a more

Websites Diarrhea